Welcome to LookChem.com Sign In|Join Free

CAS

  • or

34817-61-3

Post Buying Request

34817-61-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34817-61-3 Usage

Synonyms

Thiazetidine dioxide

Type of compound

Heterocyclic compound

Physical state

Unstable, flammable liquid

Sensitivity

Sensitive to air and moisture

Usage

a. Organic synthesis
b. Building block for pharmaceutical and agrochemical products
c. Reagent in the preparation of other organic compounds
d. Preparation of compounds with a thiazetidine ring structure

Applications

a. Medicinal chemistry
b. Drug development

Molecular structure

Unique and reactive

Safety precautions

Handle with care due to hazardous nature

Check Digit Verification of cas no

The CAS Registry Mumber 34817-61-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,8,1 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 34817-61:
(7*3)+(6*4)+(5*8)+(4*1)+(3*7)+(2*6)+(1*1)=123
123 % 10 = 3
So 34817-61-3 is a valid CAS Registry Number.

34817-61-3Upstream product

34817-61-3Relevant articles and documents

6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE AND 6,7-DIHYDRO-4H-TRIAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES

-

Page/Page column 37; 38, (2018/03/28)

The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R1 to R4 and Q are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Disruption of oligomerization and dehydroalanine formation as mechanisms for ClpP protease inhibition

Gersch, Malte,Kolb, Roman,Alte, Ferdinand,Groll, Michael,Sieber, Stephan A.

supporting information, p. 1360 - 1366 (2014/02/14)

Over 100 protease inhibitors are currently used in the clinics, and most of them use blockage of the active site for their mode of inhibition. Among the protease drug targets are several enzymes for which the correct multimeric assembly is crucial to thei

Structure-reactivity relationships in the inactivation of elastase by β-sultams

Hinchliffe, Paul S.,Wood, J. Matthew,Davis, Andrew M.,Austin, Rupert P.,Beckett, R. Paul,Page, Michael I.

, p. 67 - 80 (2007/10/03)

N-Acyl-β-sultams are time dependent irreversible active site directed inhibitors of elastase. The rate of inactivation is first order with respect to β-sultam concentration and the second order rate constants show a similar dependence on pH to that for the hydrolysis of a peptide substrate. Inactivation is due to the formation of a stable 1:1 enzyme inhibitor complex as a result of the active site serine being sulfonylated by the β-sultam. Ring opening of the β-sultam occurs by S-N fission in contrast to the C-N fission observed in the acylation of elastase by N-acylsulfonamides. Structure-activity effects are compared between sulfonylation of the enzyme and alkaline hydrolysis. Variation in 4-alkyl and N-substituted β-sultams causes differences in the rates of inactivation by 4 orders of magnitude.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 34817-61-3